Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3346-23-4

Post Buying Request

3346-23-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3346-23-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3346-23-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,4 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3346-23:
(6*3)+(5*3)+(4*4)+(3*6)+(2*2)+(1*3)=74
74 % 10 = 4
So 3346-23-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H5N5O3/c5-2-1(9(11)12)3(10)8-4(6)7-2/h(H5,5,6,7,8,10)

3346-23-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-Diamino-4-hydroxy-5-nitrosopyrimidine

1.2 Other means of identification

Product number -
Other names 2,6-diamino-5-nitro-1H-pyrimidin-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3346-23-4 SDS

3346-23-4Relevant articles and documents

Inhibition of human O6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)- (benzyloxy)-2,6(4)-diamino-5-(nitro or nitroso)pyrimidine derivatives and analogues

Terashima, Isamu,Kohda, Kohfuku

, p. 503 - 508 (1998)

A series of 4(6)-(benzyloxy)-2,6(4)-diamino-5-(nitro or nitroso)pyrimidine derivatives and analogues of which 4(6)-benzyloxy groups were replaced with a (2-, 3-, or 4-fluorobenzyl)oxy or (2-, 3-, or 4- pyridylmethyl)oxy group, was synthesized. The abilities of these compounds to inhibit human O6-alkylguanine-DNA alkyltransferase (AGAT) in vitro and to potentiate the cytotoxicity of 1-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-3- (2-chloroethyl)-3-nitrosourea (ACNU) toward HeLa S3 cells were evaluated. 2,4-Diamino-6-[(2-fluorobenzyl)oxy]-5-nitropyrimidine (3) and 2,4-diamino-5- nitro-6-(2-pyridylmethoxy)pyrimidine (6), whose ortho positions of the 6- substituent are modified, were much weaker in terms of these abilities than the corresponding meta- or para-modified compounds. These results are consistent with those of our previous study using a series of O6- benzylguanine derivatives. All 5-nitrosopyrimidine derivatives examined exerted both stronger AGAT-inhibition and ACNU-enhancement abilities than the corresponding 5-nitro derivatives. Among a variety of compounds that we have examined to date, 2,4-diamino-6-[(4-fluorobenzyl)oxy]-5-nitrosopyrimidine (10) exhibited the strongest ability to inhibit AGAT, and its magnitude was 2.5 and 50 times those of 4-(benzyloxy)-2,6-diamino-5-nitrosopyrimidine (9) and O6-benzylguanine (1), respectively. A strong positive correlation was observed between the ability to inhibit AGAT and to potentiate the cytotoxicity of ACNU. This strongly indicates that 4(6)-(benzyloxy)pyrimidine derivatives and their analogues potentiate ACNU cytotoxicity by inhibiting AGAT activity. To characterize the reactivity of test compounds, alkyl- transfer reactions were also carried out using the biomimetic alkyl-transfer system.

A 2, 4 - diamino - 5 - nitro - 6 - hydroxy pyrimidine preparation method and application thereof (by machine translation)

-

Paragraph 0039-0050, (2018/05/01)

The present invention provides a 2, 4 - diamino - 5 - nitro - 6 - hydroxy pyrimidine preparation method, comprises the following steps: in a sulfuric acid solution, 2, 4 - diamino - 6 - hydroxy pyrimidine with nitric acid nitration; after the reaction is complete, the cooling crystallization, filtering, washing, drying, to obtain 2, 4 - diamino - 5 - nitro - 6 - hydroxy pyrimidine; the invention also provides a method for preparing nitro pyrimidine 2, 4, 5 - c amino - 6 - hydroxy pyrimidine method, comprises the following steps: N in the catalyst under the action of the, nitro pyrimidine in the lye A with C1 - C4 alcohol in the mixed solution, react with hydrogen; the method of the invention preparation of guanine, not the production of the inorganic salt as a by-product, waste water generation and emissions is lowered to that of the existing technology 1/6 - 1/8. (by machine translation)

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3346-23-4